Searching News Database: menstrual migraine
HSMN NewsFeed - 11 May 2010
MAP Pharmaceuticals Provides Update on Progress of LEVADEX Development Program
MAP Pharmaceuticals Provides Update on Progress of LEVADEX Development Program
HSMN NewsFeed - 1 Dec 2009
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
HSMN NewsFeed - 10 Sep 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
HSMN NewsFeed - 16 Mar 2007
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
HSMN NewsFeed - 8 May 2006
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Additional items found! 1
Members Archive contains
1 additional stories matching:
menstrual migraine
(Password required)
menstrual migraine
(Password required)